Pre- and post-surgical immunotherapy improves outcomes for...
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery –...
MD Anderson Research Highlights for October 25, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research...
ESMO: Erdafitinib demonstrates improved responses in...
ABSTRACTS: 2359O, 2362MO
Targeted treatment with the fibroblast growth factor receptor (FGFR) inhibitor erdafitinib improved...
ESMO: PARP inhibitor plus immunotherapy lowers risk of endometrial...
ABSTRACT: LBA41
Immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab improved progression-free survival (PFS) in patients...
mRNA delivered by extracellular vesicles induces...
A team of researchers at The University of Texas MD Anderson Cancer Center has developed a new method for using extracellular vesicles...
Lactate-producing bacteria inside tumors promote resistance...
Researchers at The University of Texas MD Anderson Cancer Center have discovered that lactate-producing intratumoral bacteria drives...
MD Anderson Research Highlights: ESMO 2023 Special Edition
ABSTRACTS: LBA71, 1088MO, 95MO, LBA48, 1082O, 1085O, LBA34, 243MO
The University of Texas MD Anderson Cancer Center’s Research...
MD Anderson hosts 2023 Leading Edge of Cancer Research...
The University of Texas MD Anderson Cancer Center will host its annual Leading Edge of Cancer Research Symposium Nov. 16-17, 2023,...
Jennifer Wargo, M.D., elected to the National Academy of...
Jennifer Wargo, M.D., professor of Surgical Oncology and Genomic Medicine and core member of the James P. Allison...
MD Anderson launches collaborative initiative to reduce...
The University of Texas MD Anderson Cancer Center today announced the launch of Texas Health Equity Alliance for Breast Cancer...
MD Anderson Research Highlights for October 4, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research...
Alejandro Aballay, Pharm.D., Ph.D., named Dean of MD...
The University of Texas MD Anderson Cancer Center and The University of Texas Health Science Center at Houston today announced...